Exchange
Nasdaq Copenhagen
Every company in the roster listed on Nasdaq Copenhagen.
Research
Compare financial metrics on this exchange
Research adds market cap, cash, runway and annualized R&D metrics with metric-specific sorting.
Views
2 of 2 companies
| Company | Pipeline | Most advanced | Next readout |
|---|---|---|---|
 H. LundbeckHLUN.B · Nasdaq Copenhagen | 10 assets: 7 approved, 2 Ph 3, 1 Ph 2 | BexicaserinPhase 3 · EpilepsyPartial signal | 31 Oct 2026Bexicaserin · Phase 3 |
 Zealand PharmaZEAL · Nasdaq Copenhagen | 5 assets: 3 Ph 3, 1 Ph 2, 1 Ph 1 | dasiglucagonPhase 3 · Type 2 DiabetesReliable signal | 8 Dec 2026survodutide · Phase 1 |
Next readout: the earliest estimated primary completion of a trial the company or a partner on the asset runs (ClinicalTrials.gov).